Extracts from the root bark of Calotropis gigantea were subjected to bioactivity-guided fractionation using growth inhibitory effects against Entamoeba histolytica. The n-hexane soluble portion of the chloroform extract showed in vitro antiamoebic activity against the HK-9 strain of Entamoeba histolytica. Chromatographic separation of the chloroform extract afforded the known compound, procesterol, which showed activity against E. histolytica.
Entamoeba histolytica (E. histolytica) is a protozoan parasite causing amoebic dysentery and liver abscess. Metronidazole is effective and the most widely used medicament for treating amoebiasis, but has common side effects [1a] . Resistance against metronidazole is common in bacteria, and in vitro trophozoites of E. histolytica are able to adapt to therapeutically relevant levels of the drug [1b]. Because cross-resistance exists among the nitroimidazoles [1c], there is no equally effective and tolerated class of drug available in cases of rising resistance to metronidazole.
Plant extracts and isolated constituents have been an alternative and valuable source in the search for new anti-amoebic compounds [2a-2e] . Calotropis gigantea (Asclepiadaceae), has been used to treat dysentery. Although the leaves and root bark of C. gigantea have previously been examined [3a-3c] , there is no report to date on the anti-amoebic activity of the species. From the root bark C. gigantea, procesterol (Figure 1 ) was isolated and its structure was confirmed by comparing the spectroscopic data [4a] . Procesterol was first isolated from the fresh flowers of C. procera as a C-6 C-24 diepimer of stigmast-4-en-6β-ol-3-one [4a] and later from Erythroxylum barbatum [4b], and Cordia platythyrsa [4c]. An axenic culture of HK-9 strains of E. histolytica was maintained in Diamond's TYIS-33 medium [5a] . Metronidazole was used as the reference drug in all the biological experiments. All the plant extracts, the isolated compound, and metronidazole were dissolved in dimethylsulfoxide. The maximum concentration of DMSO in the test did not exceed 0.1%, at which level no inhibition of amoebic growth occurred [5b,5c]. IC 50 values of the plant extracts and the isolated compound were determined by a microdilution method [5d]. The percentage inhibition values obtained were transformed into probit values and regression analysis was undertaken in order to find the best fitting straight line through the point obtained. At least three experiments were performed for each compound and plant extract tested. The in vitro anti-amoebic screening results of the plant extracts and the isolated compound, procesterol, against the HK-9 strain of E. histolytica are summarized in Table 1 . It was found that the n-hexane soluble NPC Natural Product Communications 2010 Vol. 5 No. 6 867 -868 The gummy residue obtained from the methanol extract was partitioned between chloroform and water. The nhexane soluble portion of the chloroform fraction was column chromatographed over silica gel, eluting with various solvent gradients of increasing polarities. The fraction eluted with n-hexane-chloroform (3:2) was evaporated under reduced pressure and again subjected to column chromatography on silica gel. The n-hexanelight petroleum (9:11) fraction yielded a gummy residue, which on repeated crystallization from acetone to afford procesterol (90 mg Activity against E. histolytica (strain HK-9) in vitro:
This was assessed using a microtiter plate method [5d]. DMSO (40 µL) was added to a sample of either plant extract (~10 mg) or compound (~1 mg) followed by enough culture medium to obtain a concentration of either 10 or 1 mg/mL [5b,5c] . The details of the in vitro experiment were described previously [2c] . The % inhibition of amoebal growth was calculated from the optical densities of the control and test wells and plotted against the logarithm of the dose of the drug tested. Linear regression analysis was used to determine the best-fitting straight line from which the IC 50 value was determined.
